《Table 5–Pharmacokinetic parameters of azithromycin in rats after oral administration of AM-containi

《Table 5–Pharmacokinetic parameters of azithromycin in rats after oral administration of AM-containi   提示：宽带有限、当前游客访问压缩模式
本系列图表出处文件名：随高清版一同展现
《Creation of an assessment system for measuringthe bitterness of azithromycin-containing reversemicelles》


  1. 获取 高清版本忘记账户？点击这里登录
  1. 下载图表忘记账户？点击这里登录

After a logistic equation was chosen as the correlation equation and SSF 2 was selected as the dissolution medium，we compared variability.We found that after 10 min of dispersion in SSF 2，the determined and calculated concentrations of drugs released at different time points were similar（P>0.05）.In addition，the bitterness and drug release profiles of the AM-containing RMs formulation and Zithromax?were similar ateach time point after 10 min（Table 4）.Therefore，bitterness could be assessed based on drug release concentrations in SSF 2 at 15 min.

图表编号XD00186272700    严禁用于非法目的
绘制时间2018.07.01
作者Ri Huang、Yadan Zhang、Tao Wang、Liao Shen、Zhen Zhang、Yang Wang、Dongqin Quan
绘制单位Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences、Experimental Teaching Administration Department, TianjinU niversity of Traditional Chinese Medicine、Institute of Pharmacology and Toxicology, Academy of Military Medical Scienc
更多格式高清、无水印（增值服务）

相关图表

  1. 《Table 2Effect of C.dichotoma extract on nutritional parameters in rats fed high-fat diet for 4 weeks.》2018.06.01
  2. 《Table 2Effect of PAME on biochemical parameters in vincristine induced neuropathic pain in rats.》2018.03.01
  3. 《Table 1–The pharmacokinetic parameters of TMP in joint tissue and synovial fluid after intra-articular injection of TMP》2018.05.01
  4. 《Table 2–Pharmacokinetic parameters of formulations.》2018.01.01
  5. 《Table 1 Main pharmacokinetic parameters of hesperetin in rats after oral administration of hesperetin suspension, hesper》2019.03.03
  6. 《Table 3.Pharmacokinetic parameters of Pazufloxacin analyzed in plasma.》2019.01.01
  7. 《Table 5.Pharmacokinetic parameters of Pazufloxacin analyzed in urine.》2019.01.01
  8. 《Table 4.Pharmacokinetic parameters of different gender.》2019.01.01
  9. 《表1 大鼠药动学参数Tab.1 Pharmacokinetic parameters in rats》2019.02.15
  10. 《表3 大鼠静脉给予柴胡皂苷B2、B4后的药动学参数Tab.3 Main pharmacokinetic parameters of saikosaponin B2, B4 in rats after intravenous》2019.02.15
  11. 《表1 癫痫大鼠血浆内CBZ的主要药动学参数 (, n=5) Tab.1 Main pharmacokinetic parameters of plasma CBZ in epileptic rats (n=5)》2019.04.28
  12. 《Table 7 Influences of the pilot product of QFJBT on blood biochemical parameters of rats in a 3-month, repeat-dose oral》2018.12.01
  13. 《Table 6 Influences of the pilot product of QFJBT on hematological parameters of rats in a 3-month, repeat-dose oral toxi》2018.12.01
  14. 《Table 6Pharmacokinetic parameters of GRe after intravenous administration (mean±SD, n=5) .》2018.07.18
  15. 《Table 5Pharmacokinetic parameters of GRe after vaginal administration (mean±SD, n=5) .》2018.07.18
  16. 《Table 6Brain pharmacokinetic parameters of five analytes in rats after single oral administration of JTP extracts (±s, n》2018.04.18
  17. 《Table 3Pharmacokinetic parameters of normal rats singly intragastric administrated with salidroside (±s, n=8) .》2018.04.18
  18. 《表3 小鼠灌胃给药8-MOP的药代动力学参数 (n=5) Table 3 Pharmacokinetic parameters of 8-MOP in mice with a single intragastrical administra》2018.10.18
  19. 《表2 肌肉注射异丙嗪麻黄碱合剂后各组中麻黄碱的药物动力学参数 (n=6) Tab.2 Pharmacokinetic parameters of EP in different groups rats after intramuscular》2018.02.01
  20. 《Table 7–Pharmacokinetic parameters of Lop after topical application of Fc and Fop in rats (n=3) .》2018.05.01

随机翻阅

《表2 MSCTA诊断各项指标情况对比（%）》 《表1 不同原料添加量的单因素水平表g》 《表1 2组病人健康教育落实率比较[n;百分率 (%) ]》 《表1 不同水平年的人口情况》 《表1 预制率对应预制构件范围表》 《表1 典型5G基站的基本参数》 《表3 Box-Behnken试验设计及结果》 《表3 两组患者治疗前后血清炎性因子水平比较》 《表1 透水沥青混合料指标要求》 《表4 2024铝合金材料参数》